Proclin 300

ProClin biocides are immediately microstatic upon contact with microbial organisms as a result of their ability to quickly penetrate cell membranes and inhibit specific enzymes crucial to cellular respiration. Multiple specific sites of ProClin toxicity prevent microorganisms from developing high…

Components: ProClin 150 5ml; ProClin 200 5ml; ProClin 300 5ml; ProClin 950 5ml RIDADR: UN 3316 9

…Learn more. Application: Suggested starting dilutions are as follows: WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

… Suggested starting dilutions are as follows: ICC/IF: 1:100-1:1000, WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…dilutions are as follows: IHC-P: 1:100-1:1000, WB: 1:500-1:3000, IHC-Wm: 1:100-1:500. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…Optimal working dilutions should be determined experimentally by the end user. Immunogen: Synthetic peptide corresponding to a region within amino acids 781 and 874 of LGR5 according to NP_003658 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 2402 and 2513 of mtor according to NP_001070679 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…dilutions should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 204 and 410 of tuba1 according to NP_919369 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…protein. Plays a role in the activation of T-cells. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 104 and 354 of lcp1 according to NP_571395 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…experimentally by the end user. Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 354 and 568 of NS3 (Dengue virus 2) according to NP_739587 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…experimentally by the end user. Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 117 and 301 of NS1 (Dengue virus 2) according to NP_739584 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…activator. May function as a switch in neuronal development. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 42 and 238 of sox2 according to NP_998283 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 7 and 321 of gapdh according to NP_001108586 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…should be determined experimentally by the end user. Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 391 and 661 of NAT10 according to AAH35558 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…experimentally by the end user. Immunogen: Synthetic peptide containing a sequence corresponding to a region within amino acids 2 and 13 of Capsid Protein (Dengue virus 2 ) according to NP_739591 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…Required for the looping stage of heart development. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 50 and 212 of tbx5a according to NP_570990 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…by the end user. Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 495 of Envelope protein (Dengue virus 2) according to NP_739583 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…Optimal working dilutions should be determined experimentally by the end user. Immunogen: Recombinant fragment corresponding to a region within amino acids 45 and 268 of EFHA1 according to AAH31089 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…are ubiquitously expressed in all eukaryotic cells. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 30 and 375 of bactin1 according to NP_571106 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…a prominent kinase in the central nervous system. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 298 and 470 of camk2d2 according to NP_001002542 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…dilutions should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 72 and 258 of phb according to NP_958454 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…dilutions should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 445 and 664 of nat10 according to NP_956938 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…should be determined experimentally by the end user. Immunogen: Synthetic peptide containing a sequence corresponding to a region within amino acids 364 and 377 of adipor1b according to NP_998665 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…to be a plausible candidate gene for High Bone Mass Syndrome. [provided by RefSeq] Immunogen: Recombinant fragment corresponding to a region within amino acids 1 and 310 of WNT11 according to NP_004617 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…have been identified on chromosomes 1, 3, 8, 10, and 12. [provided by RefSeq] Immunogen: Recombinant fragment corresponding to a region within amino acids 1 and 360 of OCT3/4 (Uniprot ID#Q01860) Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…an isozyme of ROCK1 is a target for the small GTPase Rho. [provided by RefSeq] Immunogen: Synthetic phospho-peptide corresponding to amino acids residues surrounding the phospho Ser1366 of ROCK2 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…5-prime monophosphate (Fujishige et al., 2000 [PubMed 10998054]).[supplied by OMIM] Immunogen: Recombinant fragment corresponding to a region within amino acids 547 and 779 of PDE10A according to AAI04859 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…role during stroke, ischemic injury and ParkinsonGǦs disease. Immunogen: Synthetic peptide containing a sequence corresponding to a region within amino acids 755 and 810 of Gli1 according to NP_034426 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…Mediates cell survival during the DNA damage process through activation of CDK2. Immunogen: Recombinant fragment corresponding to a region within amino acids 1 and 313 of SPDYA according to NP_877433 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…possibly via induction of genes associated with apoptosis.[supplied by OMIM] Immunogen: Recombinant fragment corresponding to a region within amino acids 241 and 504 of ZC3H12A according to NP_079355 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…as a member of the C-54 family of cysteine proteases. [provided by RefSeq] Immunogen: Recombinant fragment corresponding to a region within amino acids 220 and 441 of ATG4D according to NP_116274 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…matrix, where the mature form is found. [provided by RefSeq] Immunogen: Recombinant fragment corresponding to a region within amino acids 110 and 412 of Citrate synthetase according to NP_938083 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.